Literature DB >> 25848481

Role of diet on non-alcoholic fatty liver disease: An updated narrative review.

Dimitrios Papandreou1, Eleni Andreou1.   

Abstract

The purpose of this article review is to update what is known about the role of diet on non-alcoholic fatty liver disease (NAFLD). NAFLD is the most common cause of chronic liver disease in the developed world and is considered to be a spectrum, ranging from fatty infiltration of the liver alone (steatosis), which may lead to fatty infiltration with inflammation known as non alcoholic steatohepatitis While the majority of individuals with risk factors like obesity and insulin resistance have steatosis, only few people may develop steatohepatitis. Current treatment relies on weight loss and exercise, although various insulin-sensitizing medications appear promising. Weight loss alone by dietary changes has been shown to lead to histological improvement in fatty liver making nutrition therapy to become a cornerstone of treatment for NAFLD. Supplementation of vitamin E, C and omega 3 fatty acids are under consideration with some conflicting data. Moreover, research has been showed that saturated fat, trans-fatty acid, carbohydrate, and simple sugars (fructose and sucrose) may play significant role in the intrahepatic fat accumulation. However, true associations with specific nutrients yet to be clarified.

Entities:  

Keywords:  Diet; Fatty acids; Insulin resistance; Non-alcoholic fatty acids; Obesity

Year:  2015        PMID: 25848481      PMCID: PMC4381180          DOI: 10.4254/wjh.v7.i3.575

Source DB:  PubMed          Journal:  World J Hepatol


  85 in total

Review 1.  Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

Authors:  Christian Thoma; Christopher P Day; Michael I Trenell
Journal:  J Hepatol       Date:  2011-07-01       Impact factor: 25.083

Review 2.  Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.

Authors:  Juan P Arab; Roberto Candia; Rodrigo Zapata; Cristián Muñoz; Juan P Arancibia; Jaime Poniachik; Alejandro Soza; Francisco Fuster; Javier Brahm; Edgar Sanhueza; Jorge Contreras; M Carolina Cuellar; Marco Arrese; Arnoldo Riquelme
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

3.  Metformin reverses fatty liver disease in obese, leptin-deficient mice.

Authors:  H Z Lin; S Q Yang; C Chuckaree; F Kuhajda; G Ronnet; A M Diehl
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

4.  The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis.

Authors:  G Leonarduzzi; A Scavazza; F Biasi; E Chiarpotto; S Camandola; S Vogel; R Dargel; G Poli
Journal:  FASEB J       Date:  1997-09       Impact factor: 5.191

5.  Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease.

Authors:  Raphael B Merriman; Linda D Ferrell; Marco G Patti; Shiobhan R Weston; Mark S Pabst; Bradley E Aouizerat; Nathan M Bass
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

6.  Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis.

Authors:  Shiro Yokohama; Masashi Yoneda; Masakazu Haneda; Satoshi Okamoto; Mituyoshi Okada; Kazunobu Aso; Takenao Hasegawa; Yoshihiko Tokusashi; Naoyuki Miyokawa; Kimihide Nakamura
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

7.  Vitamin E treatment in pediatric obesity-related liver disease: a randomized study.

Authors:  Pietro Vajro; Claudia Mandato; Adriana Franzese; Edmondo Ciccimarra; Stefania Lucariello; Marcella Savoia; Grazia Capuano; Fiorella Migliaro
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-01       Impact factor: 2.839

8.  Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).

Authors:  Siddharth Verma; Donald Jensen; John Hart; Smruti R Mohanty
Journal:  Liver Int       Date:  2013-06-13       Impact factor: 5.828

9.  Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study.

Authors:  Ariel E Feldstein; Anna Wieckowska; A Rocio Lopez; Yao-Chang Liu; Nizar N Zein; Arthur J McCullough
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

10.  Prevalence and associated metabolic factors of fatty liver disease in the elderly.

Authors:  Zhongli Wang; Ming Xu; Jianhong Peng; Li Jiang; Zhengguo Hu; Hua Wang; Shiqing Zhou; Rui Zhou; Michael Hultström; En Yin Lai
Journal:  Exp Gerontol       Date:  2013-05-27       Impact factor: 4.032

View more
  17 in total

Review 1.  Endocrine-disrupting chemicals and fatty liver disease.

Authors:  Charles E Foulds; Lindsey S Treviño; Brian York; Cheryl L Walker
Journal:  Nat Rev Endocrinol       Date:  2017-05-19       Impact factor: 43.330

Review 2.  Effects of dietary macronutrients on liver fat content in adults: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Esther Winters-van Eekelen; Inge Verkouter; Harry P F Peters; Marjan Alssema; Babette G de Roos; Vera B Schrauwen-Hinderling; Kay H M Roumans; Jan W Schoones; Peter L Zock; Patrick Schrauwen; Frits R Rosendaal; Olaf M Dekkers; Renée de Mutsert
Journal:  Eur J Clin Nutr       Date:  2020-10-22       Impact factor: 4.016

3.  Randomized Controlled Trial of a MUFA or Fiber-Rich Diet on Hepatic Fat in Prediabetes.

Authors:  Isabel Errazuriz; Simmi Dube; Michael Slama; Roberto Visentin; Sunita Nayar; Helen O'Connor; Claudio Cobelli; Swapan Kumar Das; Ananda Basu; Walter Karl Kremers; John Port; Rita Basu
Journal:  J Clin Endocrinol Metab       Date:  2017-05-01       Impact factor: 5.958

Review 4.  A weighty problem: metabolic perturbations and the obesity-cancer link.

Authors:  Ciara H O'Flanagan; Laura W Bowers; Stephen D Hursting
Journal:  Horm Mol Biol Clin Investig       Date:  2015-08

5.  CD36 genetic variation, fat intake and liver fibrosis in chronic hepatitis C virus infection.

Authors:  Omar Ramos-Lopez; Sonia Roman; Erika Martinez-Lopez; Nora A Fierro; Karina Gonzalez-Aldaco; Alexis Jose-Abrego; Arturo Panduro
Journal:  World J Hepatol       Date:  2016-09-08

6.  Major components of metabolic syndrome and nutritional intakes in different genotype of UCP2 -866G/A gene polymorphisms in patients with NAFLD.

Authors:  Mahdieh Abbasalizad Farhangi; Fatemeh Mohseni; Safar Farajnia; Mohammad-Asghari Jafarabadi
Journal:  J Transl Med       Date:  2016-06-14       Impact factor: 5.531

Review 7.  Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease.

Authors:  Manuel Suárez; Noemí Boqué; Josep M Del Bas; Jordi Mayneris-Perxachs; Lluís Arola; Antoni Caimari
Journal:  Nutrients       Date:  2017-09-22       Impact factor: 5.717

8.  Are miRNA-103, miRNA-107 and miRNA-122 Involved in the Prevention of Liver Steatosis Induced by Resveratrol?

Authors:  Ana Gracia; Alfredo Fernández-Quintela; Jonatan Miranda; Itziar Eseberri; Marcela González; María P Portillo
Journal:  Nutrients       Date:  2017-04-04       Impact factor: 5.717

9.  Egg consumption and risk of non-alcoholic fatty liver disease.

Authors:  Zeinab Mokhtari; Hossein Poustchi; Tannaz Eslamparast; Azita Hekmatdoost
Journal:  World J Hepatol       Date:  2017-04-08

10.  HepatoDyn: A Dynamic Model of Hepatocyte Metabolism That Integrates 13C Isotopomer Data.

Authors:  Carles Foguet; Silvia Marin; Vitaly A Selivanov; Eric Fanchon; Wai-Nang Paul Lee; Joan J Guinovart; Pedro de Atauri; Marta Cascante
Journal:  PLoS Comput Biol       Date:  2016-04-28       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.